News Detail
New Delhi, 15 June 2024: The National Pharmaceutical Pricing Authority (NPPA) has invoked the Para 3 of the Drugs (Prices Control) Order, 2013, and directed Mumbai-based Macleods Pharmaceuticals to supply anti-tuberculosis drug rifampicin 150 mg and 450 mg capsules to the c......
View Details
Source : Pharmabiz
NPPA
Para 3
Drugs (Prices Control) Order
Macleods Pharmaceuticals
anti-tuberculosis drug
rifampicin
Central Medical Services Society
CMSS
DPCO
2013
API
bulk drug
National Tuberculosis Elimination Programme
NTEP
Lok Sabha
Related News
- NPPA asks retailers, dealers and online pharmacies to ensure compliance of Para 24 and 25 of DPCO, 2013 (11-02-2025)
- Kerala: 12 establishments caught selling fake cosmetics, including soaps and creams, with harmful chemicals (11-02-2025)
- EMA establishes regular procedure for scientific advice on certain high-risk medical devices (11-02-2025)
- Goyal urges the pharmaceutical industry to expose those engaged in sale of counterfeit products (11-02-2025)
- WHO identifies research priorities for boosting fight against antimicrobial resistance (11-02-2025)
- Supreme Court Calls on State Officials to Address Misleading Drug Advertisements (10-02-2025)
- Cases will be initiated immediately against individuals involved in sale of intoxicants and adulteration of drugs (10-02-2025)
- An index to gauge states for drug enforcement, improve drug quality (10-02-2025)
- China's health regulator defends quality of local generic drugs (10-02-2025)
- DGFT amends standard input output norms for erythromycin stearate tablets (10-02-2025)